Growth Metrics

Equillium (EQ) Cash & Current Investments (2017 - 2026)

Equillium (EQ) reported Cash & Current Investments of $60.4 million for Q1 2026, up 316.48% year-over-year from $14.5 million in Q1 2025, and up 103.11% on a QoQ basis from $29.7 million in Q4 2025.

Equillium (EQ) has 10 years of Cash & Current Investments data on file, last reported at $60.4 million in Q1 2026.

  • Quarterly Cash & Current Investments rose 316.48% year-over-year to $60.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.4 million (up 316.48% YoY) and the FY2025 annual result came in at $29.7 million, up 31.71% from the prior year.
  • Cash & Current Investments advanced to $60.4 million in Q1 2026 per EQ's latest filing, from $29.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $71.0 million in Q4 2022 and bottomed at $11.5 million in Q2 2025.
  • The 5-year median for Cash & Current Investments is $40.9 million (2023), against an average of $41.3 million.
  • The widest annual swing landed in 2025, when Cash & Current Investments plunged 65.48%; it then jumped 316.48% in 2026.
  • Tracing EQ's Cash & Current Investments over 5 years: stood at $71.0 million in 2022, then sank by 42.46% to $40.9 million in 2023, then plunged by 44.76% to $22.6 million in 2024, then surged by 31.71% to $29.7 million in 2025, then surged by 103.11% to $60.4 million in 2026.
  • Per Business Quant, the three latest EQ Cash & Current Investments figures stand at $60.4 million (Q1 2026), $29.7 million (Q4 2025), and $33.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 2.13 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 32.30 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 61.46 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 7.25 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.75 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 3.01 Bn
10 Equillium 279.21 Mn 218.82 Mn - 60.39 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 60.39 Mn
Dec 31, 2025 29.73 Mn
Sep 30, 2025 33.12 Mn
Jun 30, 2025 11.50 Mn
Mar 31, 2025 14.50 Mn
Dec 31, 2024 22.58 Mn
Sep 30, 2024 25.88 Mn
Jun 30, 2024 33.30 Mn
Mar 31, 2024 32.29 Mn
Dec 31, 2023 40.87 Mn
Sep 30, 2023 46.31 Mn
Jun 30, 2023 48.38 Mn
Mar 31, 2023 61.99 Mn
Dec 31, 2022 71.02 Mn
Sep 30, 2022 44.52 Mn
Jun 30, 2022 57.56 Mn
Mar 31, 2022 68.82 Mn
Dec 31, 2021 80.71 Mn
Sep 30, 2021 90.69 Mn
Jun 30, 2021 97.64 Mn
Mar 31, 2021 104.08 Mn
Dec 31, 2020 82.16 Mn
Sep 30, 2020 90.54 Mn
Jun 30, 2020 42.61 Mn
Mar 31, 2020 47.68 Mn
Dec 31, 2019 53.14 Mn
Sep 30, 2019 62.24 Mn
Jun 30, 2019 56.94 Mn
Mar 31, 2019 61.61 Mn
Dec 31, 2018 65.91 Mn
Sep 30, 2018 4.98 Mn
Dec 31, 2017 7.10 Mn